Zwerling, A <br/><br/>
A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  Feb 2016 
 - 257-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.15.0415  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--administration & dosage<br/>Computer Simulation<br/>Cost-Benefit Analysis<br/>Decision Support Techniques<br/>Disability Evaluation<br/>Drug Administration Schedule<br/>Drug Costs<br/>Drug Therapy, Combination<br/>Health Services Accessibility<br/>Humans<br/>Models, Economic<br/>Monte Carlo Method<br/>Patient Selection<br/>Time Factors<br/>Treatment Outcome<br/>Tuberculosis--diagnosis